|Articles|January 6, 2017
New CEO for Amplyx Pharmaceuticals
January 06, 2017
Advertisement
Amplyx Pharmaceuticals (San Diego, CA) has appointed Ciara Kennedy, Ph.D., to president and chief executive officer and Karen Joy Shaw, Ph.D., to chief scientific officer (CSO). The company's former president and CEO, Mike Grey, has assumed the role of executive chairman of the Amplyx Board of Directors. Dr. Kennedy joined Amplyx as chief operating officer in October 2015. Prior to that, she served as vice president and cholestatic liver disease program head at Shire Pharmaceuticals, and as COO of Lumena Pharmaceuticals.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5